"ALOFT - Aliskiren Observation of Heart Failure Treatment": Efficacy and Safety of Aliskiren Added on Top of Standard Therapy in Adults (≥ 18 Years) With Stable Heart Failure

NCT00219011 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
280
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Novartis